Shire Corporate Responsiblity Report

What does corporate responsibility mean for a pharmaceutical business? Everything we do is underpinned by a strong sense of our responsibilities as a specialty biopharmaceutical company.

From detailed business policies to practical day-to-day action, the idea of corporate responsibility guides and inspires everyone who works at Shire.

Download 2008 highlights PDF

Brave New World

2008 has been a pivotal year for Shire in many ways. A new CEO, a new phase in the Company’s strategy, and a new clarity about how the business is organized and what it aims to achieve.
News in brief

A selection of stories from across Shire, from ‘Engaging with our employees’ to ‘Entering new markets’, ‘Supporting science in education’ to ‘Working with patient groups’.
Customer engagement

An update on the 2007 report where we talked about the work we were doing to improve our customer care.
Ethical marketing

A long-term aim is to launch our portfolio of ADHD treatments in Europe. In a time where the causes and consequences of ADHD are still not fully appreciated, this is potentially a very significant market for us.
The environment

This time last year we’d just launched ‘SAVE’—Shire’s Actions and Values for the Environment. We're improving our environmental performance and are making Shire a greener place to work.
Shire in the community

Shire took part in hundreds of different community activities in 2008, ranging from individual employee fundraising and volunteering, to bigger projects like Project Playground.
CR objectives

Our CR policy highlights our adoption of a set of core principles. Our principles provide a framework for managing risk and maintaining Shire's position as a good corporate citizen.
CR data bank

Whether you need our environmental performance, EHS statistics or employee information, look no further here are all the facts and figures!
Awards and recognition

From top rankings in our industry to how we perform in our local communities around the Shire globe, we’ve had an exceptional year and received some outstanding accolades for both the Company and our dedicated employees.

Message from Angus Russell

Chief Executive Officer

Report from Tatjana May

General Counsel, Company Secretary, Executive Vice President Global Legal Affairs and Chairman CR Committee

Meet the CR Committee

"As European General Manager for Human Genetic Therapies, my contribution to the Committee is to guide Shire in its relationships with physicians and patient organisations."

Theresa Heggie

Vice President and General Manager Shire HGT Europe